SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Forssell Aronsson Eva) srt2:(2005-2009)"

Search: WFRF:(Forssell Aronsson Eva) > (2005-2009)

  • Result 1-10 of 32
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Brandberg, John, 1966, et al. (author)
  • Accurate tissue area measurements with considerably reduced radiation dose achieved by patient-specific CT scan parameters
  • 2008
  • In: British Journal of Radiology. - : British Institute of Radiology. - 1748-880X .- 0007-1285. ; 81:970, s. 801-8
  • Journal article (peer-reviewed)abstract
    • A low-dose technique was compared with a standard diagnostic technique for measuring areas of adipose and muscle tissue and CT numbers for muscles in a body composition application. The low-dose technique was intended to keep the expected deviation in the measured area of adipose and muscle tissue to <1% of the total tissue area. The largest diameter of the patient determined the parameters for the low-dose technique. 17 patients - chosen to cover a wide range of diameters (31-47 cm) for both abdomen and thighs - were examined using both techniques. Tissue areas were compared, as were CT numbers for muscle tissue. Image noise was quantified by standard deviation measurements. The area deviation was <1%, except in the smallest subjects, in whom it was <2%. The integral radiation dose of the low-dose technique was reduced to 2-3% for diameters of 31-35 cm and to 7.5-50% for diameters of 36-47 cm as compared with the integral dose by the standard diagnostic technique. The CT numbers of muscle tissue remained unchanged with reduced radiation dose. Image noise was on average 20.9 HU (Hounsfield units) for subjects with diameters of 31-35 cm and 11.2 HU for subjects with diameters in the range of 36-47 cm. In conclusion, for body composition studies with CT, scan protocols can be adjusted so that the integral dose is lowered to 2-60% of the standard diagnostic technique at our centre without adversely altering area measurements of adipose and muscle tissue and without altering CT numbers of muscle tissue.
  •  
2.
  • Bernhardt, Peter, 1966, et al. (author)
  • Effects of treatment with (177)Lu-DOTA-Tyr(3)-octreotate on uptake of subsequent injection in carcinoid-bearing nude mice.
  • 2007
  • In: Cancer biotherapy & radiopharmaceuticals. - : Mary Ann Liebert Inc. - 1084-9785 .- 1557-8852. ; 22:5, s. 644-53
  • Journal article (peer-reviewed)abstract
    • PURPOSE: The aim of this study was to analyze the effect therapeutic injections of (177)Lu-DOTA(0)-Tyr(3)]-octreotate (DOTATATE) had on the tumor uptake of a subsequent injection with (111)In-DOTATATE in GOT1-bearing nude mice. METHODS AND MATERIALS: Nude mice, xenografted with the human midgut carcinoid, GOT1, were first intravenously injected with a curative (30 MBq) or a suboptimal (7.5 MBq) amount of (177)Lu-DOTATATE. At various intervals thereafter (4-13 days), a second injection with (111)In-DOTATATE (0.5 MBq) was given. One (1) day after the second injection, the animals were sacrificed, tumor tissues collected, the tumor (111)In and (177)Lu activity concentration determined, and tumor regression/cell density was recorded. RESULTS: In animals given curative amounts, the uptake of (111)In was lower than in untreated animals. On the other hand, a second late injection (3-13 days) after suboptimal amounts resulted in a twofold higher tumor activity concentration versus untreated animals. When the uptake of the curative injection was corrected for tumor cell density, which decreased from 66% to 4% over 2 weeks, an enhanced uptake per tumor cell was observed. The curative and suboptimal amounts resulted in a different uptake and retention of (177)Lu in tumors. The suboptimal amount resulted in a constant activity concentration, while the curative amount resulted in an increased activity concentration over time. CONCLUSIONS: Our results, as presented in this paper, describe how the second injection in a fractionation protocol will be affected by the first therapeutic amount. This new information might be useful in the optimization of radionuclide therapy.
  •  
3.
  • Bernhardt, Peter, 1966, et al. (author)
  • Estimation of metastatic cure after radionuclide therapy.
  • 2007
  • In: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology. - 1824-4785. ; 51:4, s. 297-303
  • Journal article (peer-reviewed)abstract
    • Targeted radionuclide therapy of disseminated tumor disease involves many factors that will affect the therapeutic outcome. For optimization of such therapy, it is important to know how these factors affect the therapeutic outcome. In this paper, the metastatic cure probability (MCP) model is described. The MCP model is a valuable tool for analyses of the various factors influencing the metastatic cure. The factors discussed are: 1) the physical parameters (the energy and range of emitted particles, absorbed dose-distributions, and cross-irradiation of tumors from the surrounding normal tissue) and 2) the biological parameters (radiosensitivity of tumors, tumor distributions, tumor growth rate, metastasis formation rate, variable tumor activity concentration and non-homogeneous tumor activity distributions).
  •  
4.
  • Carlsson, Åsa, 1978, et al. (author)
  • Accurate and sensitive measurements of magnetic susceptibility using echo planar imaging.
  • 2006
  • In: Magnetic resonance imaging. - : Elsevier BV. - 0730-725X. ; 24:9, s. 1179-85
  • Journal article (peer-reviewed)abstract
    • Susceptibility differences are common causes for artifacts in magnetic resonance (MR); therefore, it is important to choose phantom materials in a way that these artifacts are kept at a minimum. In this study, a previously proposed MR imaging (MRI) method [Beuf O, Briguet A, Lissac M, Davis R. Magnetic resonance imaging for the determination of magnetic susceptibility of materials. J Magn Reson 1996; Series B(112):111-118] was improved to facilitate sensitive in-house measurements of different phantom materials so that such artifacts can more easily be minimized. Using standard MRI protocols and distilled water as reference, we measured magnetic volume susceptibility differences with a clinical MR system. Two imaging techniques, echo planar imaging (EPI) and spin echo, were compared using liquid samples whose susceptibilities were verified by MR spectroscopy. The EPI sequence has a very narrow bandwidth in the phase-encoding direction, which gives an increased sensitivity to magnetic field inhomogeneities. All MRI measurements were evaluated in two ways: (1) manual image analysis and (2) model fitting. The narrow bandwidth of the EPI made it possible to detect very small susceptibility differences (equivalent susceptibility difference, Deltachi(e)> or =0.02 ppm), and even plastics could be measured. Model fitting yielded high accuracy and high sensitivity and was less sensitive to other image artifacts as compared with manual image analysis.
  •  
5.
  • Forssell-Aronsson, Eva, 1961, et al. (author)
  • Aspects on radionuclide therapy in malignant pheochromocytomas.
  • 2006
  • In: Annals of the New York Academy of Sciences. - : Wiley. - 0077-8923. ; 1073, s. 498-504
  • Journal article (peer-reviewed)abstract
    • Malignant pheochromocytomas/paragangliomas (PCs/PGs) often have distant metastases to the skeleton, liver, and lungs. Radionuclide therapy is valuable for treatment of disseminated tumor disease and could be used as adjuvant therapy after surgery. Patients with local and/or distant metastases of PC/PG should be investigated preoperatively by scintigraphy using both 123I-MIBG and 111In-DTPA-D-Phe1-octreotide, to evaluate the possibilities for radionuclide therapy (i.e., a dosimetric estimation of radiation dose to the tumor tissue versus critical normal tissues). Individual patient dose-planning should be performed. For patients in whom positive therapeutic effects are anticipated radionuclide therapy can be applied. Therapy with both 131I-MIBG and 177Lu-octreotate might be favorable in individual patients with lesions visualized by both metaiodobenzylguanidine (MIBG) and octreotide scintigraphy with enhanced therapeutic effects and reduced side effects.
  •  
6.
  •  
7.
  • Kölby, Lars, 1963, et al. (author)
  • Can quantification of VMAT and SSTR expression be helpful for planning radionuclide therapy of malignant pheochromocytomas?
  • 2006
  • In: Annals of the New York Academy of Sciences. - : Wiley. - 0077-8923. ; 1073, s. 491-7
  • Journal article (peer-reviewed)abstract
    • Tumor-specific uptake of the radio-iodinated norepinephrine analogue meta-iodobenzylguanidine (MIBG) or uptake of radiolabeled somatostatin analogues via somatostatin receptors (SSTRs) are possibilities to diagnose and treat malignant pheochromocytomas/paragangliomas (PCs/PGs). The aims of this study were to investigate the quantitative expression of vesicular monoamine transporters (VMAT 1, 2) and all five SSTRs in malignant pheochromocytoma/paraganglioma (PC/PG) to evaluate the possibilities for tumor-specific radionuclide therapy. High scintigraphic 123I-MIBG uptake was found in two malignant PGs with high VMAT expression (500-730 copies of VMAT 1, 1,500-1,700 copies of VMAT 2 per 1,000 beta-actin), while no 123I-MIBG uptake was found in the malignant PG with low VMAT expression (330 copies of VMAT 1, 350 copies of VMAT 2 per 1,000 beta-actin). The two patients with high VMAT expression and high 123I-MIBG uptake were treated with 131I-MIBG (2-3x8 GBq). In vitro, the VMAT antagonist, reserpine, and the membrane pump inhibitor, clomipramine, inhibited the uptake of 123I-MIBG into tumor cells equally well (48% and 53% reduction respectively, P<0.001). SSTR2 was the most abundant receptor subtype, but in the two malignant PGs its expression was only 110-260 copies/1,000 beta-actin. The transporters at the cell membrane and in the vesicular membrane both appear to be of importance for the uptake of 123I-MIBG into malignant PC/PG. Quantitative determination of VMAT expression may be helpful in selecting patients suitable for radionuclide therapy with 131I-MIBG. The present data indicate that SSTR-mediated radionuclide therapy will not be effective treatment of malignant PC/PG.
  •  
8.
  • Kölby, Lars, 1963, et al. (author)
  • Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour
  • 2005
  • In: British journal of cancer. - : Springer Science and Business Media LLC. - 0007-0920 .- 1532-1827. ; 93:10, s. 1144-51
  • Journal article (peer-reviewed)abstract
    • Somatostatin receptor (sstr)-mediated radiation therapy is a new therapeutic modality for neuroendocrine (NE) tumours. High expression of sstr in NE tumours leads to tumour-specific uptake of radiolabelled somatostatin analogues and high absorbed doses. In this study, we present the first optimised radiation therapy via sstr using [(177)Lu-DOTA(0)-Tyr(3)]-octreotate given to nude mice xenografted with the human midgut carcinoid GOT1. The tumours in 22 out of 23 animals given therapeutic amounts showed dose-dependent, rapid complete remission. The diagnostic amount (0.5 MBq [(177)Lu-DOTA(0)-Tyr(3)]-octreotate) did not influence tumour growth and was rapidly excreted. In contrast, the therapeutic amount (30 MBq [(177)Lu-DOTA(0)-Tyr(3)]-octreotate) induced rapid tumour regression and entrapment of (177)Lu so that the activity concentration of (177)Lu remained high, 7 and 13 days after injection. The entrapment phenomenon increased the absorbed dose to tumours from 1.6 to 4.0 Gy MBq(-1) and the tumours in animals treated with 30 MBq received 120 Gy. Therapeutic amounts of [(177)Lu-DOTA(0)-Tyr(3)]-octreotate rapidly induced apoptosis and gradual development of fibrosis in grafted tumours. In conclusion, human midgut carcinoid xenografts can be cured by receptor-mediated radiation therapy by optimising the uptake of radioligand and taking advantage of the favourable change in biokinetics induced by entrapment of radionuclide in the tumours.
  •  
9.
  • Lagerstrand, Kerstin M, et al. (author)
  • Flow-induced disturbances in balanced steady-state free precession images: means to reduce or exploit them.
  • 2009
  • In: Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. - : Wiley. - 1522-2594. ; 61:4, s. 893-8
  • Journal article (peer-reviewed)abstract
    • In this work computer simulations and phantom measurements are presented that show the effect of flow on in-plane balanced steady-state free precession images. The images were studied for various flow velocities, excitation regions, relaxation times, RF-pulse angles, and off-resonance frequencies. The work shows that flow-induced disturbances are present in the images, but can be reduced by the application of inhomogeneous excitation regions. Also, a velocity quantification method that utilizes the disturbances was developed and proved to quantify flow velocities accurately. The work concluded that the flow-induced disturbances can be reduced to improve image quality, but can also be exploited to quantify the flow velocity.
  •  
10.
  • Lagerstrand, Kerstin M, et al. (author)
  • Quantitative phase-contrast flow MRI measurements in the presence of a second vessel closely positioned to the examined vessel.
  • 2006
  • In: Journal of magnetic resonance imaging : JMRI. - : Wiley. - 1053-1807 .- 1522-2586. ; 23:2, s. 156-62
  • Journal article (peer-reviewed)abstract
    • PURPOSE: To examine the influence of the truncated sampling of k-space data on the accuracy of phase-contrast (PC) flow quantifications in the presence of nearby vessels. MATERIALS AND METHODS: Computer simulations were performed along with some experimental validations on a flow phantom and a normal subject. RESULTS: The accuracy of the PC flow quantification decreased when a second vessel was positioned closely to the examined vessel. The effect strongly depended on the peak flow velocity in the second vessel relative to the velocity encoding (venc) level of the MRI acquisition, and on the position and area of the second vessel. CONCLUSION: Due to the truncated sampling of the k-space data, signal leaked from nearby vessels and distorted the PC flow quantification in the examined vessel. The presented results suggest specific experimental conditions to minimize this flow quantification error.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-10 of 32
Type of publication
journal article (31)
conference paper (1)
Type of content
peer-reviewed (31)
other academic/artistic (1)
Author/Editor
Forssell-Aronsson, E ... (32)
Bernhardt, Peter, 19 ... (16)
Ahlman, Håkan, 1947 (10)
Nilsson, Ola, 1957 (8)
Starck, Göran (7)
Kölby, Lars, 1963 (6)
show more...
Nilsson, Mikael, 195 ... (6)
Lundh, Charlotta, 19 ... (4)
Ljungberg, Maria (4)
Lindencrona, Ulrika, ... (4)
Wängberg, Bo, 1953 (3)
Johanson, Viktor, 19 ... (3)
Oddstig, Jenny, 1978 (3)
Jansson, Svante, 194 ... (2)
Lagerstrand, Kerstin ... (2)
Muth, Andreas, 1974 (2)
Ekholm, Sven (2)
Carlsson, Therese, 1 ... (2)
Carlsson, Arvid, 192 ... (2)
Törnqvist, Margareta (1)
Karlsson, Mikael (1)
Mattsson, Sören (1)
Ziegelitz, Doerthe (1)
Wikkelsö, Carsten, 1 ... (1)
Tullberg, Mats, 1965 (1)
Knutsson, Linda (1)
Sjöström, Lars (1)
Tisell, Lars-Eric, 1 ... (1)
Khorram-Manesh, Amir ... (1)
Stridsberg, Mats (1)
Larsson, Fredrik, 19 ... (1)
Lönn, Lars, 1956 (1)
Harms-Ringdahl, Mats (1)
Swärd, Christina, 19 ... (1)
Jacobsson, Lars, 194 ... (1)
Montelius, Mikael, 1 ... (1)
Riklund-Åhlström, Ka ... (1)
Bergelin, Eva, 1950 (1)
Sundqvist, Göran, 19 ... (1)
Ivarsson, Tord, 1946 (1)
Bardies, Manuel (1)
Lundberg, Stefan (1)
Brandberg, John, 196 ... (1)
Ericsson, Thomas, 19 ... (1)
Rudling, Jan (1)
Nylén, Torbjörn (1)
Edsbagge, Mikael (1)
Carlsson, Maria L., ... (1)
Chouin, Nicolas (1)
Nordh, Sture (1)
show less...
University
University of Gothenburg (32)
Lund University (2)
Uppsala University (1)
Chalmers University of Technology (1)
Language
English (31)
Swedish (1)
Research subject (UKÄ/SCB)
Medical and Health Sciences (22)
Social Sciences (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view